申请人:Eli Lilly and Company
公开号:US05786356A1
公开(公告)日:1998-07-28
The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective .beta.3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and method of treating type II diabetes, comprising administering to a mammal in need thereof compounds of the Formulas I and II: ##STR1##
本发明属于医学领域,特别是涉及治疗2型糖尿病和肥胖的领域。更具体地说,本发明涉及用于治疗2型糖尿病和肥胖的选择性β3肾上腺素受体激动剂。该发明提供了化合物和治疗2型糖尿病的方法,包括给予需要的哺乳动物化合物I和II的方法:##STR1##